Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Revenue (2016 - 2025)

Nephros (NEPH) has 16 years of Revenue data on record, last reported at $4.8 million in Q3 2025.

  • For Q3 2025, Revenue rose 35.42% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $17.9 million, up 32.36%, while the annual FY2024 figure was $14.2 million, 0.53% down from the prior year.
  • Revenue reached $4.8 million in Q3 2025 per NEPH's latest filing, up from $4.4 million in the prior quarter.
  • Across five years, Revenue topped out at $4.9 million in Q1 2025 and bottomed at $2.2 million in Q1 2022.
  • Average Revenue over 5 years is $3.3 million, with a median of $3.3 million recorded in 2023.
  • Peak YoY movement for Revenue: decreased 21.09% in 2022, then surged 71.24% in 2023.
  • A 5-year view of Revenue shows it stood at $2.6 million in 2021, then dropped by 0.78% to $2.6 million in 2022, then increased by 27.21% to $3.3 million in 2023, then rose by 18.93% to $3.9 million in 2024, then increased by 23.1% to $4.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $4.8 million in Q3 2025, $4.4 million in Q2 2025, and $4.9 million in Q1 2025.